Open Access Highly Accessed Email this article to a friend

What is the future of targeted therapy in rheumatology: biologics or small molecules?

Attila Mócsai*, László Kovács and Péter Gergely

BMC Medicine 2014, 12:43  doi:10.1186/1741-7015-12-43

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Medicine's emails?